US Is Home to More Than 18 Million Cancer Survivors
There were more than 18 million cancer survivors in the United States at the beginning of this year, according to new data.
There were more than 18 million cancer survivors in the United States at the beginning of this year, according to new data.
Researchers identified demographic and socioeconomic factors associated with differences in staging of non-small cell lung cancer at initial presentation.
The pooled incidence of chemoradiation-induced grade 3-5 pneumonitis was 3.62% in randomized trials, 5.98% in observational studies, and 7.85% in observational studies of platinum doublet chemotherapy.
African-American patients were more likely to be eligible for lung cancer screening using USPSTF’s 2021 criteria vs 2013 criteria.
Findings persist across racial/ethnic groups, regardless of government or private insurance, and across facility types.
The incidence of advanced lung cancer declined by 3 cases per 100,000 people per year in 2015-2018 relative to 2004-2014.
The percentage of patients with stage I disease increased from 23.5% in 2010 to 29.1% in 2017.
The overall response rate was 33%, with 1% of patients having complete responses and 32% having partial responses.
TACTI-002, enrolled 114 patients with untreated locally advanced or metastatic non-small cell lung cancer, unselected for PD-L1 expression.
The researchers noted that responses were deep, with 75% of responders achieving a greater than 50% tumor reduction.